IL6 and rheumatoid arthritis: Rheumatoid Arthritis drugs recommended by The American College of Rheumatology (ACR) fall into several categories: small molecule DMARDs including methotrexate, lefluonamide and others; anti-TNF-α agents; T-cell activation modulators; IL-6 antagonists; IL-1 antagonists; and B-cell directed therapy.